Correction: The interplay between obesity, immunosenescence, and insulin resistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: The interplay between obesity, immunosenescence, and insulin resistance ; volume:21 ; number:1 ; day:15 ; month:5 ; year:2024 ; pages:1-2 ; date:12.2024
Immunity & ageing ; 21, Heft 1 (15.5.2024), 1-2, 12.2024
- Urheber
-
Shimi, Ghazaleh
Sohouli, Mohammad Hassan
Ghorbani, Arman
Shakery, Azam
Zand, Hamid
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12979-024-00438-z
- URN
-
urn:nbn:de:101:1-2407242121208.891911465409
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
30.03.20252025, 21:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shimi, Ghazaleh
- Sohouli, Mohammad Hassan
- Ghorbani, Arman
- Shakery, Azam
- Zand, Hamid
- SpringerLink (Online service)
Ähnliche Objekte (12)
The interplay between obesity, immunosenescence, and insulin resistance
Fatty Acids, Obesity and Insulin Resistance
Microglial activation during obesity-induced insulin resistance
Hypothalamic Inflammation in Obesity, Insulin Resistance and Ageing
Macrophage function in obesity-induced inflammation and insulin resistance
Vaspin (serpinA12) in obesity, insulin resistance, and inflammation
Biomarkers of obesity-mediated insulin resistance: focus on microRNAs
Insulin resistance and obesity: how do they affect tau pathology?
Mechanism of insulin resistance in obesity: a role of ATP
FGF21 gene therapy as treatment for obesity and insulin resistance
The impact of myeloid cell restricted insulin receptor deficiency on obesity induced insulin resistance
The impact of myeloid cell restricted insulin receptor deficiency on obesity induced insulin resistance
The interplay between obesity, immunosenescence, and insulin resistance
Fatty Acids, Obesity and Insulin Resistance
Microglial activation during obesity-induced insulin resistance
Hypothalamic Inflammation in Obesity, Insulin Resistance and Ageing
Macrophage function in obesity-induced inflammation and insulin resistance
Vaspin (serpinA12) in obesity, insulin resistance, and inflammation
Biomarkers of obesity-mediated insulin resistance: focus on microRNAs
Insulin resistance and obesity: how do they affect tau pathology?
Mechanism of insulin resistance in obesity: a role of ATP
FGF21 gene therapy as treatment for obesity and insulin resistance
The impact of myeloid cell restricted insulin receptor deficiency on obesity induced insulin resistance
The impact of myeloid cell restricted insulin receptor deficiency on obesity induced insulin resistance
The interplay between obesity, immunosenescence, and insulin resistance
Fatty Acids, Obesity and Insulin Resistance
Microglial activation during obesity-induced insulin resistance
Hypothalamic Inflammation in Obesity, Insulin Resistance and Ageing
Macrophage function in obesity-induced inflammation and insulin resistance
Vaspin (serpinA12) in obesity, insulin resistance, and inflammation
Biomarkers of obesity-mediated insulin resistance: focus on microRNAs
Insulin resistance and obesity: how do they affect tau pathology?
Mechanism of insulin resistance in obesity: a role of ATP
FGF21 gene therapy as treatment for obesity and insulin resistance
The impact of myeloid cell restricted insulin receptor deficiency on obesity induced insulin resistance